-transparent.png){kind=logo}
Inducers and inhibitors of the microsomal mixed function oxidase system have no consistent effect upon the nephrotoxicity of p-aminophenol, or on binding of the compound in vivo to cell protein. p-[ring-3H]Aminophenol was bound in vitro to kidney microsomal protein and to a lesser extent to liver. The binding was enhanced by preincubation of the p-aminophenol in air and inhibited by ascorbate, GSH, N2 and NADPH. These findings indicate that in contrast to paracetamol hepatoxicity which is dependent upon the mixed function oxidase system, that nephrotoxicity of p-aminophenol is dependent upon oxidation to a toxic metabolite by some other pathway. A similar metabolite may be responsible for the nephrotoxic action of phenacetin.
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
December 1985,
Toxicology and applied pharmacology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
June 1983,
Toxicology and applied pharmacology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
July 1992,
Toxicology and applied pharmacology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
August 1999,
Drug and chemical toxicology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
September 1982,
Toxicology and applied pharmacology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
August 1996,
Clinica chimica acta; international journal of clinical chemistry,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
February 1990,
The Journal of biological chemistry,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
April 2015,
Drug and chemical toxicology,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
January 2002,
Drug metabolism reviews,
I C Calder, and
A C Yong, and
R A Woods, and
C A Crowe, and
K N Ham, and
J D Tange
May 2013,
The Medical letter on drugs and therapeutics,
